Karyopharm Appoints Michael Mano as Senior Vice President, General Counsel
“Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of Michael Mano as Senior Vice President, General Counsel. Mr. Mano brings over 15 years of legal experience and previously served as Counsel, Business Development at Biogen Inc.,” was posted on Karyopharm Therapeutics’ Press Releases.
“Prior to Biogen, Mr. Mano served as Senior Counsel at Proskauer Rose LLP. Mr. Mano holds a Bachelor’s degree from Saint Michael’s College and a Juris Doctorate from Washington University in St. Louis School of Law.”
